ARTICLE | Clinical News
Avastin bevacizumab regulatory update
April 13, 2015 7:00 AM UTC
The European Commission approved an expanded label for Avastin bevacizumab in combination with standard chemotherapy to treat adults with persistent, recurrent or metastatic carcinoma of the cervix. T...